Prevention of HIV Infection Among Key Populations 

Objective

To reduce new cases of HIV and other socially significant infections among key populations through the implementation of comprehensive public health prevention measures and by ensuring timely access to medical and social services.

Target Groups

  • • people who inject drugs;
  • • people who provide sexual services for remuneration;
  • • transgender people;
  • • close social networks of representatives of key populations.

Key Activities

Within this program, AUCO Convictus Ukraine implements a comprehensive package of services aimed at HIV prevention, early detection of socially significant diseases, and ensuring continuity of treatment, including:

  • • rapid testing for HIV and hepatitis C with pre- and post-test counseling;
  • • tuberculosis screening and referral to healthcare facilities in case of symptoms or suspected disease;
  • • provision of information, education, and communication services on HIV prevention and health promotion;
  • • counseling on pre-exposure prophylaxis (PrEP);
  • • distribution of harm reduction and personal protective supplies, including sterile syringes, needles, condoms, and lubricants;
  • • social support and case management for people who receive a positive HIV test result to ensure timely access to treatment and medical supervision.

Geographical Coverage

Kyiv City, Kyiv Region, and Chernihiv Region.

Partnership and Support

The project is implemented with the support of the Public Health Center of the Ministry of Health of Ukraine, in partnership with the All-Ukrainian Charitable Foundation “Drop In Center” and the NGO “Club Eney.”

Contact Persons:
Andrii Kolesov — Project Manager, Kyiv City and Chernihiv Region, kolesov@convictus.org.ua

Oleksandr Volontyr — Project Manager, Kyiv Region, volontyr@convictus.org.ua

Valentyn Shevchuk — Project Manager, Kyiv City and Kyiv Region, shevchuk@convictus.org.ua

  • Program Area
    Ensuring accessible and sustainable prevention and treatment services for socially significant diseases through innovative and systemic programs.